TPST
Tempest Therapeutics Inc
NASDAQ: TPST · HEALTHCARE · BIOTECHNOLOGY
$1.74
+2.96% today
Updated 2026-04-29
Market cap
$24.67M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.33
Dividend yield
—
52W range
$2 – $12
Volume
0.2M
Tempest Therapeutics Inc (TPST) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-203.60%
ROA
-56.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-2.73M | — | — | — |
| 2012 | — | $-13.51M | — | — | — |
| 2013 | — | $-29.04M | — | — | — |
| 2014 | $9.73M | $-49.52M | 100.00% | -492.38% | -508.68% |
| 2015 | $277000.00 | $-73.22M | -711.91% | -25,992.42% | -26,432.85% |
| 2016 | $653000.00 | $-82.26M | -727.11% | -12,406.13% | -12,597.24% |
| 2017 | $295000.00 | $-84.58M | 90.51% | -6,943.05% | -28,670.51% |
| 2018 | — | $-27.19M | — | — | — |
| 2019 | — | $-44.57M | — | — | — |
| 2020 | $0.00 | $-19.12M | — | — | — |
| 2021 | $0.00 | $-28.30M | — | — | — |
| 2022 | $0.00 | $-35.71M | — | — | — |
| 2023 | $0.00 | $-29.49M | — | — | — |
| 2024 | $0.00 | $-41.84M | — | — | — |
| 2025 | $0.00 | $-26.26M | — | — | — |